Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥10.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥19.5bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Operating income¥7m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥11m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥190m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Profit before tax−¥54m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥44m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥292m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥44m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥13.6bnat 2022-09-30Cons.Assets
Total assets¥14.2bnat 2022-03-31Cons.Assets
Total liabilities¥10.5bnat 2022-09-30Cons.Liabilities
Total liabilities¥11.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.1bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.2bnat 2022-03-31Cons.Net assets
Cash and deposits¥1.3bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥1.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.2bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2022-03-31Cons.Cash and cash equivalents
Operating cash flow¥676m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥919m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥103m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥446m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥2.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-17.832022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.092022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥117.492021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥116.612021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio22.9%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio22.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 23
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥430m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥13m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥17m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥13m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥13m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥393m
jpcrp040300-q2r_E36714-000Medicinereportable segmentrevenue2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E36714-000Medicinereportable segmentrevenue external2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E36714-000Medicinereportable segmentsegment profit2022-04-01 → 2022-09-30¥240m
jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.8bn
jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.8bn
jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segmentsegment profit2022-04-01 → 2022-09-30−¥61m
jpcrp040300-q2r_E36714-000Nurturing Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E36714-000Nurturing Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E36714-000Nurturing Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥204m
—segment totalrevenue2022-04-01 → 2022-09-30¥10.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥10.5bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥383m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥10.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥10.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥13m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥400m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 410
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)史彩監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)伊  藤     肇
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)田  和  大  人
Number of submissionFilingDateInstant1
Net sales (5-year summary)CurrentYTDDuration10931326000JPY
Net sales (5-year summary)Prior1YearDuration19510261000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration-11227000JPY
Ordinary income loss (5-year summary)Prior1YearDuration189986000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration-44372000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration291566000JPY
Comprehensive income (5-year summary)CurrentYTDDuration-44338000JPY
Comprehensive income (5-year summary)Prior1YearDuration291628000JPY
Net assets (5-year summary)CurrentQuarterInstant3116160000JPY
Net assets (5-year summary)Prior1YearInstant3202696000JPY
Total assets (5-year summary)CurrentQuarterInstant13614290000JPY
Total assets (5-year summary)Prior1YearInstant14205288000JPY
Basic earnings loss per share (5-year summary)CurrentYTDDuration-17.83
Basic earnings loss per share (5-year summary)Prior1YearDuration117.49
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration116.61
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.229
Equity to asset ratio (5-year summary)Prior1YearInstant0.225
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration676420000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration918914000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-103484000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-2534428000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-445904000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration2011347000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant1213880000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant1086848000JPY
Basic earnings loss per share (5-year summary)CurrentQuarterDuration3.09
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2488700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2488700
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant2488700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant2488700
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember836100
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.3359
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember567900
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.2281
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember100000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0401
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember100000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0401
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember60000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0241
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember58400
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0234
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember40000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0160

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 11 of 11 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass